poly-iclc
Showing 1 - 8 of 8
Low-Grade B-cell Lymphoma Trial in New York (rhuFlt3L/CDX-301, Poly-ICLC)
Recruiting
- Low-Grade B-cell Lymphoma
- rhuFlt3L/CDX-301
- Poly-ICLC
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 17, 2020
Solid Tumors Trial in New York (Peptides, Poly-ICLC, Lenalidomide)
Completed
- Solid Tumors
- Peptides
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jan 7, 2021
Influenza, Severe Acute Respiratory Distress Syndrome, Smallpox Trial run by the NIAID (Poly-ICLC)
Completed
- Influenza
- +4 more
- Poly-ICLC
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Melanoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Skin Trial in New York (Poly-ICLC)
Terminated
- Melanoma
- +5 more
- Poly-ICLC
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 21, 2017
Glioblastoma Multiforme, Astrocytoma, Grade IV Trial in Saint Louis (Personalized peptide vaccine, Poly-ICLC, Temozolomide)
Terminated
- Glioblastoma Multiforme
- Astrocytoma, Grade IV
- Personalized peptide vaccine
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 15, 2017
Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,
Withdrawn
- Non Small Cell Lung Cancer
- +5 more
- Pembrolizumab
- +2 more
- (no location specified)
Dec 5, 2016
HIV-1 Infection, HIV Infection, Healthy Volunteers Trial in New York (DCVax-001, Poly-ICLC, Placebo)
Completed
- HIV-1 Infection
- +2 more
- DCVax-001
- +2 more
-
New York, New YorkRockefeller University
May 7, 2014
B Cell Lymphoma, T Cell Lymphoma Trial in Las Vegas (Poly-ICLC)
Terminated
- B Cell Lymphoma
- T Cell Lymphoma
- Poly-ICLC
-
Las Vegas, NevadaNevada Cancer Institute
Jul 19, 2011